1. Hamzehloei T, Hosseini SA, Vakili R, Mojarad M. Mutation spectrum of the PAH gene in the PKU patients from Khorasan Razavi province of Iran. Gene 2012; 506(1): 230-2.

2. Koochmeshgi J, Bagheri A, Hosseini-Mazinani SM. Incidence of phenylketonuria in Iran estimated from consanguineous marriages. Inherit Metab Dis 2002; 25(1): 80-1.

3. Hosseini-Mazinani SM, Koochmeshgi J, Kha‌zaee- Koohpar Z, Hosein-Pur-Nobari N, Seifati SM, Carrier detection of phenylketonuria in Iranian families by variable number tandem-repeat poly‌mor‌phism analysis. East Mediterr Health J 2008; 14(6): 1445–51.

4. Zare-Karizi S, Hossini–Mazinani SM, Khazaei-ko‌o‌hpar Z, Seifati SM, Shahsavan-behboodi B, Akbari MT et al. Mutation spectrum of phenyl‌keto‌nuria in Iranian population. Mol Genet Metab 2011; 102(1): 29-32.

5. Fazeli Z, Vallian S. Phenylketonuria from gen‌et‌ics to clinics: An Iranian prospect. Iran J Biotech 2011; 9(3): 163-72.

6. Moradi K, Alibakhshi R, Ghadiri K, Khatami SR, Galehdari H. Molecular analysis of exons 6 and 7 of phenylalanine hydroxylase gene mutations in Phenylketonuria patients in Western Iran. Indian J Hum Genet 2012; 18(3): 290.

7. Alibakhshi R, Moradi K, Biglari M, Shafieenia S. Spectrum of phenylalanine hydroxylase gene mutations in Hamadan and Lorestan provinces of iran and their associations with variable number of tandem repeat alleles. Iran J Med Sci 2018; 43(3): 318-23.

8. Aulehla-Scholz C, Heilbronner H. Mutational spectrum in german patients with phenylalanine hydroxylase deficiency. Hum Mutation Mutation Brief 2003; 21(4): 1-6.

9. Razipour M , Alavinejad E, Sajedi SZ, Talebi S, Entezam M, Mohajer N, et al. Genetic study of the PAH locus in the Iranian population: familial gene mutations and minihaplotypes. Metabolic Brain Dis 2017; 32(5): 1685–91.

10. Shirzad T, Saeidian AH, Bagherian H, Saleh‌pour S, Setoodeh A, Alaei M, et al. Molecular gene‌t‌ics of a cohort of 635 cases of phenylketonuria in a consanguineous population. J Inherit Metab Dis 2018; 1-9.

11. Binaafar S, Mahdieh N. Genetics of Phenyl‌ketonuria in Iran: A Review Study. J Mazandaran Univ Med Sci 2017; 27(147): 446-55. [in Persian]

12. Haerian Ardakani H, Khazaei Koohpar Z, Moha‌mmadian S. Mutations Analysis of exon 10 - 11 of phenylalanine Hydroxylase gene in phenyl‌ketonuria patients from Golestan province. Razi J Med Sci 2018; 25(172): 38-46.

13. Alibakhshi R., Moradi K , Mohebbi Z, Ghadiri K. Mutation analysis of PAH gene in patients with PKU in western Iran and its association with poly‌morphisms: identification of four novel mutations. Metab Brain Dis 2014; 29(1): 131-8.

14. Biglari A, Saffari F, Rashvand Z, Alizadeh S, Najafipour R, Sahmani M, et al. Mutations of the pheny‌lalanine hydroxylase gene in Iranian patients with phenylketonuria. Springerplus 2015; 4(1): 542.

15. Alavinejad E, Sajedi SZ, Razipour M, Entezam M, Mohajer N, Setoodeh A et al. A novel variant in the PAH gene causing phenylketonuria in an iranian pedigree. Avicenna J Med Biotechnol 2017; 9(3): 146-9.

16. Bonyadi M, Omrani O, Mohamadi Mogha‌nj‌oghi S, Shiva S. Mutations of the phenylalanine hydroxylase gene in Iranian Azeri Turkish patients with phenylketonuria. Genet Test Mol Biomarkers 2010; 14(2): 233-5.

17. Daniele A, Cardillo G, Pennino C, Carbone MT, Scognamiglio D, Correra A, et al. Molecular epidemiology of phenylalanine hydroxylase deficie‌n‌cy in southern Italy: a 96% detection rate with ten novel mutations. Ann Hum Genet 2006; 71(2): 185–93.

18. Dobrowolski SF, Ellingson C, Coyne T, Grey J, Martin R, Naylor EW, et al. Mutations in the phenylalanine hydroxylasegene identified in 95 patients with phenylketonuria using novel systems of mutation scanning and specific genotyping based upon thermal melt profiles. Mol Genet Metab 2007; 91: 218–27.

19. Bercovich D, Elimelech A, Zlotogora J, Korem S, Yardeni T, Gal N, et al. Genotype–phenotype cor‌relations analysis of mutations in the phenyl‌ala‌nine hydroxylase (PAH) gene. J Hum Genet 2008; 53(5): 407–18.

20. De Lucca M, Arias I, Casique L, Araujo K, Merzon RM. Improving phenylketonuria geno‌ty‌p‌ing by screening for the IVS4+5g>t mutation in the PAH gene. Clin Chim Acta 2009; 402(1-2): 206–8.

21. Dobrowolski SF, Heintz C, Miller T, Ellingson C, Ellingson C, Özer I, et al. Molecular genetics and impact of residualin vitrophenylalanine hydroxylase activity on tetrahydrobiopterin responsiveness in Turkish PKU population. Mol Genet Metab 2011; 10: 116-21.

22. Baturina OA, Morozov IV. Comparative ana‌lysis of phenylalanine hydroxylase mutations spe‌c‌t‌‌rum in Novosibirsk and Kemerovo regions of Western Siberia, Russia. Eur J Med 2016; 11(1): 4-11.